EXHIBIT 32.1

              SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report (the "Report") of China
Biopharmaceuticals Holdings, Inc. (the "Company") on Form 10-QSB for the quarter
ended June 30, 2007 as filed with the Securities and Exchange Commission on the
date hereof, I, Chris Peng Mao, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act
of 2002, that to my knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material
aspects, the financial condition and results of operations of the Company.


Date: August 14, 2007                 By: /s/ Chris Peng Mao
                                          -----------------------------------
                                                  Chris Peng Mao
                                                  Chief Executive Officer